18+ · Research Use Only · Not for Human Consumption
Retatrutide · Phase 3 · Ongoing
TRIUMPH-OUTCOMES
TRIUMPH-OUTCOMES is a phase 3 trial of retatrutide in adults living with obesity (cardiovascular and kidney outcomes), registered as NCT06383390 and not yet reported (ClinicalTrials.gov, checked 23 September 2026).
Primara Labs sells some of the compounds covered here. Every figure on this page links to its source and the date it was checked.
Design
Trial design and sources
- Compound
- Retatrutide
- Phase
- 3
- Population
- Adults living with obesity
- Participants randomised
- Not published
- Duration
- Not published
- Primary endpoint
- Cardiovascular and kidney outcomes
- Estimand
- Not stated in the source read
- Read out
- Not yet reported
- ClinicalTrials.gov record, active, not recruiting open · checked 23 September 2026
- Registry: NCT06383390
Questions
TRIUMPH-OUTCOMES, answered
What did TRIUMPH-OUTCOMES find?
TRIUMPH-OUTCOMES is a phase 3 trial of retatrutide in adults living with obesity (cardiovascular and kidney outcomes), registered as NCT06383390 and not yet reported (ClinicalTrials.gov, checked 23 September 2026).
When will TRIUMPH-OUTCOMES report?
TRIUMPH-OUTCOMES is active and not recruiting on ClinicalTrials.gov (NCT06383390); no results have been published. Checked 23 September 2026.